Section of Investigative Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, UK.
Clin Endocrinol (Oxf). 2013 Oct;79(4):558-63. doi: 10.1111/cen.12179. Epub 2013 May 20.
Kisspeptin is a novel hypothalamic peptide which stimulates endogenous gonadotrophin releasing hormone (GnRH) secretion. A single subcutaneous bolus injection of kisspeptin-54 increases circulating luteinizing hormone (LH) levels in women, but its acute effects on LH pulsatility are not known.
To investigate the effects of a single subcutaneous (sc) injection of kisspeptin-54 administration on LH pulsatility in healthy female volunteers.
Six healthy female adult volunteers underwent 10-minute blood sampling for serum LH measurement for 8 h during the follicular phase of menstrual cycle. Sc bolus injection of saline or kisspeptin-54 (0·15, 0·30 or 0·60 nmol/kg) was administered 4 h after commencing the study. A previously described, blinded deconvolution method was used to detect LH pulses.
Mean number of LH pulses was increased significantly following 0·30 and 0·60 nmol/kg kisspeptin-54 when compared with saline (mean increase in number of LH pulses per 4 h, following injection: -0·17 ± 0·54, saline; +2·33 ± 0·56, 0·30 nmol/kg kisspeptin-54, P < 0·05 vs saline; +2·33 ± 0·80, 0·60 nmol/kg kisspeptin-54, P < 0·05 vs saline). LH pulse secretory mass increased following injection of 0·60 nmol/kg in five of six subjects, but the mean change in all subjects was non-significant when compared with saline (mean increase in pulse secretory mass in IU/l following injection: +0·35 ± 0·40, saline; +2·61 ± 1·17, 0·60 nmol/kg kisspeptin-54, P = 0·10 vs saline).
A single injection of kisspeptin-54 temporarily stimulates the number of LH pulses in healthy women. Further studies are required to investigate the therapeutic potential of kisspeptin-54 injection to restore LH pulsatility in patients with reproductive disorders caused by impaired GnRH secretion.
Kisspeptin 是一种新型的下丘脑肽,可刺激内源性促性腺激素释放激素(GnRH)的分泌。单次皮下推注 kisspeptin-54 可增加女性循环黄体生成素(LH)水平,但目前尚不清楚其对 LH 脉冲性的急性影响。
研究单次皮下(sc)注射 kisspeptin-54 对健康女性志愿者 LH 脉冲性的影响。
6 名健康成年女性志愿者在月经周期卵泡期的 8 小时内进行 10 分钟的血清 LH 测量采血。在研究开始后 4 小时,sc 推注盐水或 kisspeptin-54(0·15、0·30 或 0·60nmol/kg)。使用先前描述的、盲法去卷积方法来检测 LH 脉冲。
与盐水相比,注射 0·30 和 0·60nmol/kg kisspeptin-54 后,LH 脉冲数明显增加(每 4 小时 LH 脉冲数的增加量,注射后:-0·17±0·54,盐水;+2·33±0·56,0·30nmol/kg kisspeptin-54,P<0·05 与盐水相比;+2·33±0·80,0·60nmol/kg kisspeptin-54,P<0·05 与盐水相比)。在 6 名受试者中的 5 名中,注射 0·60nmol/kg kisspeptin-54 后 LH 脉冲分泌量增加,但与盐水相比,所有受试者的平均变化均无统计学意义(注射后脉冲分泌量的平均变化 IU/l:+0·35±0·40,盐水;+2·61±1·17,0·60nmol/kg kisspeptin-54,P=0·10 与盐水相比)。
单次注射 kisspeptin-54 可暂时刺激健康女性的 LH 脉冲数。需要进一步的研究来探讨 kisspeptin-54 注射恢复因 GnRH 分泌受损而导致生殖障碍患者 LH 脉冲性的治疗潜力。